Professor Michael Burstein discusses the United States Supreme Court's decision against Myriad Genetics—and the practical and legal implications of the gene patenting ruling. 

"It's a terrific victory for professor Dan Ravicher here at Cardozo who fought his case for many years," said Professor Burstein. "But it's not a loss for the biotechnology industry as a whole."